Posts Tagged ‘ELSI’

Ending on a high note – Day 3 of TMM2016

Author: Camila Londono, 10/31/16

Though the last day of the Till and McCulloch Meetings was a short one, it was absolutely fantastic. The day began with a thought-provoking talk by Douglas Sipp, from the Riken Center for Developmental Biology, touching upon the many issues surrounding regulation of stem cell therapies. I think as scientists, we often tend to forget…Read more

Lobbying for deregulation of stem cell procedures is giving rise to a new “dark economy”

Author: Hamideh Emrani, 10/31/16

Day 3 of the Till & McCulloch Meetings continued with many interesting talks. The one that I have chosen to write about in more detail Dr. Douglas Sipp’s, titled “The Stem Cell Dark Economy.” I think his talk was really thought provoking, and important to be shared with our readers. He began with an old…Read more

Taking appropriate steps towards gene editing in Canada

Author: Guest, 09/29/16

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in August, I had the pleasure of attending a gene editing/CRISPR workshop, hosted by…Read more

View from the floor 3: Till & McCulloch Meetings

Author: David Kent, 05/02/12

  Anticipatory ethics and the problem of expectations One of my favorite things about Canadian Stem Cell Network meetings (now renamed the Till and McCulloch Meetings) is the integration into the main programming of Ethical, Legal, and Social Issues (ELSI). It forces scientists to think outside of their own research and gives ELSI researchers exposure to the…Read more